Biochemical Effects of Personalized Clinical Interventions on Hepatorenal Function, Immune Response, and Inflammatory Markers in Patients with Infections

Hepatorenal–Immune Biomarker Changes

  • Ying Li PeKing University People's Hospital
  • Ying Zhou PeKing University People's Hospital
  • Jie Zhang PeKing University People's Hospital
  • Yi Li PeKing University People's Hospital
  • Xin Liu PeKing University People's Hospital
DOI: https://doi.org/10.5937/jomb0-62921
Keywords: Personalized intervention, Infection, Hepatorenal biomarkers, Immune function, Inflammatory cytokines

Abstract


Background: Hepatic and renal dysfunction, immune imbalance, and excessive inflammatory activation are common complications in postoperative infections. This study evaluated the biochemical effects of personalized clinical interventions on hepatorenal function, immune responses, and inflammatory cytokines in infected patients.

Methods: A total of 110 patients with postoperative infections admitted between January 2023 and January 2025 were randomly assigned to an experimental group or a control group (n = 55 each). The control group received standard clinical care, while the experimental group underwent additional individualized intervention measures. Serum hepatic (AST, ALT) and renal (BUN, SCr, UA) biochemical markers, T-lymphocyte subsets (CD3⁺, CD4⁺, CD8⁺), inflammatory factors (IL-6, CRP, TNF-α), and SF-36 quality-of-life scores were assessed before and after intervention. Adverse events were recorded.

Results: Post-intervention, AST and ALT levels were significantly lower in the experimental group compared with the control group (P < 0.05). BUN, SCr, and UA were also significantly reduced after individualized intervention (P < 0.05). The experimental group demonstrated higher CD3⁺ and CD4⁺ levels and lower CD8⁺ levels than the control group (P < 0.05). Levels of IL-6, CRP, and TNF-α were markedly decreased in the experimental group (P < 0.05). Quality-of-life scores across all domains were significantly higher following individualized intervention (P < 0.05). The incidence of adverse reactions was notably lower in the experimental group (5.45% vs. 20.00%; χ² = 4.010, P = 0.045).

Conclusion: Personalized clinical interventions significantly improved hepatic and renal biochemical indices, enhanced immune function, and reduced systemic inflammatory cytokines in patients with postoperative infections. These findings support the integration of individualized strategies into infection management to optimize biochemical and clinical outcomes.

References

1. Fabre V, Sharara SL, Salinas AB, Carroll KC, Desai S, Cosgrove SE. Does This Patient Need Blood Cultures? A Scoping Review of Indications for Blood Cultures in Adult Nonneutropenic Inpatients. Clin Infect Dis 2020; 71(5): 1339-47.
2. Skyman E, Sjostrom HT, Hellstrom L. Patients' experiences of being infected with MRSA at a hospital and subsequently source isolated. Scand J Caring Sci 2010; 24(1): 101-7.
3. Salomao MC, Freire MP, Levin ASS. Patients with carbapenem-resistant Enterobacteriaceae in emergency room; is this a real problem? Future Microbiol 2019; 14: 1527-30.
4. Mondy K, Overton ET, Grubb J, Tong S, Seyfried W, Powderly W, et al. Metabolic syndrome in HIV-infected patients from an urban, midwestern US outpatient population. Clin Infect Dis 2007; 44(5): 726-34.
5. Guan C, Wu Y, Wang X, He Y, Zhang Y, Wang M. The performance of interferon gamma release assays in patients with nontuberculous mycobacterial infection: a systematic review and meta-analysis. Eur J Clin Microbiol 2023; 42(10): 1251-62.
6. Fourgeaud J, Lecuit MM, Perot P, Bruneau J, Regnault B, Da Rocha N, et al. Chronic Aichi Virus Infection As a Cause of Long-Lasting Multiorgan Involvement in Patients With Primary Immune Deficiencies. Clin Infect Dis 2023; 77(4): 620-8.
7. Kongsiriwattanakul S, Suankratay C. Central nervous system infections in HIV-infected patients hospitalized at King Chulalongkorn Memorial Hospital. J Med Assoc Thai 2011; 94(5): 551-8.
8. Lewis CE, Montgomery K. Primary care physicians' refusal to care for patients infected with the human immunodeficiency virus. West J Med 1992; 156(1): 36-8.
9. Askin O, Altunkalem RN, Altinisik DD, Uzuncakmak TK, Tursen U, Kutlubay Z. Cutaneous manifestations in hospitalized patients diagnosed as COVID-19. Dermatol Ther 2020; 33(6): e13896.
10. Oliver NT, Skalweit MJ. Outpatient Parenteral Antibiotic Therapy in Older Adults. Infect Dis Clin N Am 2023; 37(1): 123-37.
11. Merrick B, Tan MKI, Bisnauthsing K, Goldenberg SD. Healthcare resource use in hospitalized patients with carbapenem-resistant Gram-negative infections. J Hosp Infect 2021; 110: 7-14.
12. Tan J, Huang Z, Tang W, Liu G, Li P, Wen J, et al. Human bocavirus-1 infection in hospitalized pediatric patients with acute respiratory tract infections. Microbiol Spectr 2025; 13(4): e0298524.
13. Fairbank R. Long COVID still has no cure - so these patients are turning to research. Nature 2024; 628(8006): 26-8.
14. Gompels MM, Simpson N, Snow M, Spickett G, Ong E. Desensitization to co-trimoxazole (trimethoprim-sulphamethoxazole) in HIV-infected patients: is patch testing a useful predictor of reaction? J Infection 1999; 38(2): 111-5.
15. van Bentum P, Swanink CMA, van Lochem EG, Claassen MAA, Gisolf EH, Hassing R. Prevalence of latent tuberculous infection among HIV-infected patients in a Dutch out-patient clinic. Int J Tuberc Lung D 2018; 22(4): 467-8.
16. Daftary A, Padayatchi N. Integrating patients' perspectives into integrated tuberculosis-human immunodeficiency virus health care. Int J Tuberc Lung D 2013; 17(4): 546-51.
17. Yokoyama Y, Yamakawa T, Hirano T, Kazama T, Hirayama D, Wagatsuma K, et al. Current Diagnostic and Therapeutic Approaches to Cytomegalovirus Infections in Ulcerative Colitis Patients Based on Clinical and Basic Research Data. Int J Mol Sci 2020; 21(7):
18. Nelson RE, Hyun D, Jezek A, Samore MH. Mortality, Length of Stay, and Healthcare Costs Associated With Multidrug-Resistant Bacterial Infections Among Elderly Hospitalized Patients in the United States. Clin Infect Dis 2022; 74(6): 1070-80.
19. Conway L, Moore C, Coleman BL, McGeer A. Frequency of hand hygiene opportunities in patients on a general surgery service. Am J Infect Control 2020; 48(5): 490-5.
20. Knodle R, Demers L, Simmons R. Infectious Complications in Injection Drug Use. MedEdPORTAL 2021; 17: 11124.
21. Budoff G, Thangamathesvaran L, Zarbin MA, Bhagat N. Bacterial Endogenous Endophthalmitis in Bacteremic Inpatients. Ophthalmol Retina 2019; 3(11): 971-8.
22. Li Y, Friedman JY, O'Neal BF, Hohenboken MJ, Griffiths RI, Stryjewski ME, et al. Outcomes of Staphylococcus aureus infection in hemodialysis-dependent patients. Clin J Am Soc Nephro 2009; 4(2): 428-34.
Published
2025/12/31
Issue
Ahead of print
Section
Original paper

Copyright (c) 2025 Ying Li, Ying Zhou, Jie Zhang, Yi Li, Xin Liu

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.